ArticleOncoimmunology2021

DNMT1 constrains IFNβ-mediated anti-tumor immunity and PD-L1 expression to reduce the efficacy of radiotherapy and immunotherapy.

Kevin Chih-Yang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.